[go: up one dir, main page]

SV2009003205A - Derivados de silicio para obtencion de imagenes por tomografia de emision de positrones (pet) - Google Patents

Derivados de silicio para obtencion de imagenes por tomografia de emision de positrones (pet)

Info

Publication number
SV2009003205A
SV2009003205A SV2009003205A SV2009003205A SV2009003205A SV 2009003205 A SV2009003205 A SV 2009003205A SV 2009003205 A SV2009003205 A SV 2009003205A SV 2009003205 A SV2009003205 A SV 2009003205A SV 2009003205 A SV2009003205 A SV 2009003205A
Authority
SV
El Salvador
Prior art keywords
pet
positron emission
emission tomography
obtaining images
silicon derivatives
Prior art date
Application number
SV2009003205A
Other languages
English (en)
Inventor
Ananth Srinivasan
Lutz Lehmann
Ulrike Roehn
Aileen Hoehne
Linjing Mu
Timo Stellfeld
Simon Ametamey
Ulrich Klar
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP06076823A external-priority patent/EP1908472A1/en
Priority claimed from EP06076869A external-priority patent/EP1911452A1/en
Priority claimed from EP07090043A external-priority patent/EP1970064A1/en
Priority claimed from EP07090079A external-priority patent/EP1985624A3/en
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of SV2009003205A publication Critical patent/SV2009003205A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/13—Labelling of peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/695—Silicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/004—Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/008—Peptides; Proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0834—Compounds having one or more O-Si linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0896—Compounds with a Si-H linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/12—Organo silicon halides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C07K7/086—Bombesin; Related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nuclear Medicine (AREA)
  • Peptides Or Proteins (AREA)

Abstract

NUEVOS COMPUESTOS ADECUADOS PARA SER MARCADOS O YA MARCADOS RADIOACTIVAMENTE CON 18F, MÉTODOS PARA PREPARAR DICHOS COMPUESTOS Y USO DE LOS MISMOS PARA DIAGNOSTICO POR IMÁGENES. LOS COMPUESTOS RADIOACTIVOS SE CARACTERIZAN POR LA FORMULA II, EN LA CUAL F, R1, R2, B1,2, Y1,2, Z1,2 Y E TIENEN LOS VALORES QUE SE DEFINEN EN LA MEMORIA DESCRIPTIVA Y LAS REIVINDICACIONES
SV2009003205A 2006-10-02 2009-04-02 Derivados de silicio para obtencion de imagenes por tomografia de emision de positrones (pet) SV2009003205A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP06076823A EP1908472A1 (en) 2006-10-02 2006-10-02 Silicon derivatives for PET imaging
EP06076869A EP1911452A1 (en) 2006-10-11 2006-10-11 Silicon-derivates for PET-Imaging
EP07090043A EP1970064A1 (en) 2007-03-12 2007-03-12 Silicon-derivatives for pet-imaging
EP07090079A EP1985624A3 (en) 2007-04-23 2007-04-23 Single step method of radiofluorination of biologically active compounds or biomolecules

Publications (1)

Publication Number Publication Date
SV2009003205A true SV2009003205A (es) 2009-10-19

Family

ID=39030886

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2009003205A SV2009003205A (es) 2006-10-02 2009-04-02 Derivados de silicio para obtencion de imagenes por tomografia de emision de positrones (pet)

Country Status (21)

Country Link
US (1) US20090035215A1 (es)
EP (1) EP2074135A2 (es)
JP (1) JP2010505776A (es)
KR (1) KR20090085599A (es)
AR (1) AR062795A1 (es)
AU (1) AU2007304508A1 (es)
BR (1) BRPI0719956A2 (es)
CA (1) CA2664700A1 (es)
CO (1) CO6180444A2 (es)
CR (1) CR10703A (es)
IL (1) IL197817A0 (es)
MA (1) MA30824B1 (es)
MX (1) MX2009003617A (es)
NO (1) NO20091735L (es)
PA (1) PA8747601A1 (es)
PE (1) PE20081173A1 (es)
SV (1) SV2009003205A (es)
TN (1) TN2009000100A1 (es)
TW (1) TW200820988A (es)
UY (1) UY30596A1 (es)
WO (1) WO2008040441A2 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9285360B2 (en) 2010-01-25 2016-03-15 Institut National De La Sante Et De La Recherche Medicale (Inserm) Silylated biomolecules
JP5717138B2 (ja) * 2011-05-23 2015-05-13 独立行政法人産業技術総合研究所 タンパク質固定化表面修飾材料
WO2014196540A1 (ja) * 2013-06-06 2014-12-11 日産化学工業株式会社 アルコキシシラン化合物、液晶配向剤、液晶配向膜及び液晶表示素子
US10800797B2 (en) 2015-05-26 2020-10-13 California Institute Of Technology Heteroaromatic silicon-fluoride-acceptors useful for 18F labeling of molecules and biomolecules, and methods of preparing same
WO2019055825A1 (en) 2017-09-15 2019-03-21 The Regents Of The University Of California INHIBITION OF AMINOACYLASE 3 (AA3) IN THE TREATMENT OF CANCER
WO2021226076A1 (en) * 2020-05-04 2021-11-11 The Research Foundation For The State University Of New York Positron imaging tomography imaging agent composition and method for detection of bacterial infection
ES3021138T3 (en) * 2020-09-28 2025-05-26 National Institutes For Quantum Science And Tech Method for producing radioactive labeled substance, device for producing radioactive labeled substance, and method for evaporating and concentrating radioactive metal nuclide

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5084555A (en) * 1989-08-21 1992-01-28 The Administrators Of The Tulane Educational Fund An octapeptide bombesin analog
US5732578A (en) * 1995-02-24 1998-03-31 Hyundai Metal Co., Ltd. Device for maintaining the horizontality of a door lock lever
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
US6639076B1 (en) * 1998-08-18 2003-10-28 Eli Lilly And Company Growth hormone secretagogues
AU5414000A (en) * 1999-06-14 2001-01-02 Eli Lilly And Company Compounds
WO2002044144A2 (en) * 2000-11-30 2002-06-06 Advanced Research And Technology Institute, Inc. Nucleophilic approach for preparing radiolabeled imaging agents and associated compounds
GB0206750D0 (en) * 2002-03-22 2002-05-01 Amersham Plc Radiofluorination methods
WO2004073650A2 (en) * 2003-02-20 2004-09-02 University Of South Florida Peptidomimetic inhibitors of stat3 activity and their medical uses
GB0305704D0 (en) * 2003-03-13 2003-04-16 Amersham Plc Radiofluorination methods
JP2007524677A (ja) * 2004-02-13 2007-08-30 ザ ユニバーシティ オブ ブリティッシュ コロンビア 放射性標識化合物及び組成物、それらの前駆体及びそれらの製造方法
US20080029548A1 (en) * 2006-05-05 2008-02-07 Ann De Wree Fabric treatment dispensing package

Also Published As

Publication number Publication date
UY30596A1 (es) 2008-05-02
AU2007304508A1 (en) 2008-04-10
MA30824B1 (fr) 2009-10-01
NO20091735L (no) 2009-06-30
IL197817A0 (en) 2009-12-24
US20090035215A1 (en) 2009-02-05
PE20081173A1 (es) 2008-11-06
CO6180444A2 (es) 2010-07-19
WO2008040441A3 (en) 2009-01-08
AR062795A1 (es) 2008-12-03
JP2010505776A (ja) 2010-02-25
WO2008040441A2 (en) 2008-04-10
TN2009000100A1 (en) 2010-08-19
CR10703A (es) 2009-06-25
BRPI0719956A2 (pt) 2014-04-29
KR20090085599A (ko) 2009-08-07
MX2009003617A (es) 2009-04-22
CA2664700A1 (en) 2008-04-10
PA8747601A1 (es) 2009-08-26
AU2007304508A8 (en) 2009-05-14
TW200820988A (en) 2008-05-16
EP2074135A2 (en) 2009-07-01

Similar Documents

Publication Publication Date Title
SV2009003205A (es) Derivados de silicio para obtencion de imagenes por tomografia de emision de positrones (pet)
ES2525932T3 (es) Derivados de dihidrotetrabenazina radiomarcados y su uso como agentes de imagenología
EA201100301A1 (ru) Daa-пиридин в качестве лиганда периферического бензодиазепинового рецептора для диагностической визуализации и фармацевтического лечения
CR10694A (es) Compuestos antagonistas del receptor de glucagon, composiciones que contienen dichos compuestos y procedimientos de uso
MX373153B (es) Derivados de diazacarbazol como ligandos de tau para tomografía por emisión de positrones (pet).
NO20091428L (no) Forbindelser og metoder for 18F-merkede midler
EA201301334A1 (ru) Меченные радиоактивными изотопами ингибиторы глутаминилциклазы
PA8747701A1 (es) Métodos de marcación con flúor radioactivo
GT200400146A (es) Derivados sustituidos del dioxido de tiazol-benzoisotiazol, procedimiento para su preparacion y su uso
PE20161323A1 (es) Compuestos de triazolopiridina, composiciones y metodos de uso de los mismos
EA201300176A2 (ru) Композиция контрастной среды с эффектом контрастного усиления включением высококонцентрированного контрастного агента
ATE538135T1 (de) Verbindungen auf peptidbasis
WO2009134405A3 (en) Substrate based pet imaging agents
CY1113022T1 (el) Ακτινoφαρμακευτικες συνθεσεις οι οποιες περιεχουν πολυσακχαριτες εμβολιασμενους με πολυαμιδια
JP2016505506A5 (es)
ES2484068B1 (es) Una composición farmacéutica que contiene ketamina y amitriptilina
ATE439869T1 (de) Automatisches radioaktives markierungsverafhren
WO2009025914A3 (en) Radiolabelled fluorobenzamide analogues, their synthesis and use in diagnostic imaging
NO20092813L (no) Radiomerking via fluorinering av aziridiner
DOP2009000060A (es) Derivados de silicio para obtencion de imágenes por tomografia de emision de positrones (pet)
WO2008151003A3 (en) Novel fluorine-18 labeled rhodamine derivatives for myocardial perfusion imaging with positron emission tomography
JP2015500873A5 (es)
KR102219895B9 (ko) 쯔쯔가무시병 진단용 조성물 및 이를 포함하는 키트
ATE521591T1 (de) 11c-markierte benzyl-lactam-verbindungen und deren verwendung als bildgebungsmittel
RU2015133164A (ru) Радиоактивно-меченые соединения

Legal Events

Date Code Title Description
FD Lapse